Appili Therapeutics Inc (APLI) — Cash Flow-to-Debt Ratio
Appili Therapeutics Inc (APLI) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of CA$-293.07K could theoretically repay 0% of its total liabilities (CA$16.93 Million) in one year. See APLI FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Appili Therapeutics Inc Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Appili Therapeutics Inc across 9 annual periods. Also explore net asset momentum of Appili Therapeutics Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Appili Therapeutics Inc (2017–2025)
Year-by-year debt coverage analysis for Appili Therapeutics Inc. For market capitalisation and broader financial context, see Appili Therapeutics Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | CA$868.82K | CA$16.43 Million | ▲ +126.6% |
| 2024 | -0.20x | CA$-2.46 Million | CA$12.42 Million | ▲ +79.3% |
| 2023 | -0.96x | CA$-10.10 Million | CA$10.53 Million | ▲ +41.9% |
| 2022 | -1.65x | CA$-19.08 Million | CA$11.55 Million | ▲ +19.7% |
| 2021 | -2.06x | CA$-11.45 Million | CA$5.56 Million | ▼ -12.5% |
| 2020 | -1.83x | CA$-4.26 Million | CA$2.33 Million | ▼ -27.8% |
| 2019 | -1.43x | CA$-3.46 Million | CA$2.42 Million | ▼ -0.7% |
| 2018 | -1.42x | CA$-3.30 Million | CA$2.32 Million | ▲ +20.6% |
| 2017 | -1.79x | CA$-2.14 Million | CA$1.19 Million | — |